Drug Trial Radar · NCT05246137
A Phase III Trial to Assess the Safety and Immunogenicity of a HIPRA's Candidate Booster Vaccination Against COVID-19.
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,661
Actual
Start
Feb 3, 2022
Primary completion
Mar 3, 2023
Study completion Mar 3, 2023
Sponsor
- Lead sponsor
- Hipra Scientific, S.L.UIndustry
- Sponsor type
- Industry
- First posted
- Feb 18, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a phase III clinical study to assess the safety, tolerability and immunogenicity of PHH-1V as a booster dose in healthy adult subjects vaccinated against COVID-19 with the Comirnaty, Spikevax, Vaxevria or Janssen vaccine.
Conditions
- SARS-CoV-2 Infection
Interventions
COVID-19 Vaccine 40 ug/doseBiological
Intramuscular injection of 0,5 ml with 40 ug of recombinant PHH-1V
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Treatment-Emergent Adverse Events (Safety and tolerability)Time frame: Day 7
- Incidence of Treatment-Emergent Adverse Events (Safety and tolerability) (AEs)Time frame: Day 28
- Incidence of Serious Adverse Events (Safety and tolerability) (SAE)Time frame: Day 365
- Incidence of Special Interest Adverse Events (Safety and tolerability) (AESI).Time frame: Day 365
- Incidence of Medically Attended Adverse Events (Safety and tolerability) (MAAEs)Time frame: Day 365
- Incidence of Adverse Events in laboratory parameters (Safety and tolerability)Time frame: Day 365
Locations
18 sites in 2 countries. Site status is shown where the registry gives one.
Hospital de Niguarda
Milan, Milano, Italy
Hospital HM Delfos
Barcelona, Barcelona, Spain
Hospital Quironsalud Barcelona
Barcelona, Barcelona, Spain
Hospital de Mollet
Mollet del Vallès, Barcelona, Spain
Hospital Germans Trias I Pujol
Badalona, BARCELONA, Spain
Hospital Vall Hebron
Barcelona, BARCELONA, Spain
Hospital Universitari Dr. Josep Trueta
Girona, Girona, Spain
Hospital Gregorio Marañón
Madrid, Madrid, Spain
Hospital Universitario La Paz
Madrid, Madrid, Spain
Hospital HM Sanchinarro
Madrid, Madrid, Spain
Hospital Quironsalud Madrid
Madrid, Madrid, Spain
Hospital HM Montepríncipe
Madrid, Madrid, Spain
Hospital Principe de Asturias
Meco, Madrid, Spain
Hospital HM Puerta del Sur
Móstoles, Madrid, Spain
Hospital Regional Universitario de Málaga
Málaga, Málaga, Spain
Hospital Clinic de Barcelona
Barcelona, Spain, Spain
Hospital Clínico de Valencia
Valencia, Valencia, Spain
Hospital de Cruces
Barakaldo, VIZCAYA, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.